Clinical and financial benefits of intra-articular tranexamic acid in total knee arthroplasty

Journal of Orthopaedic Surgery

Volumn 24, Issue 1, 2016, Pages 3-6

  Goyal, Navendu ^a   Chen, Darren B ^a   Harris, Ian A ^b   Rowden, Neville ^c   Kirsh, George ^d   MacDessi, Samuel J ^a  

^a University of New South Wales ^*  (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c St George Clinical School   (Australia)

^d St George Private Hospital   (Australia)

Author keywords

Arthroplasty; Blood loss; Cost benefit analysis; Knee; Replacement; Surgical; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

AGED; ARTHROPATHY; BLOOD TRANSFUSION; COST CONTROL; FEMALE; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KNEE REPLACEMENT; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RETROSPECTIVE STUDY;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; COST SAVINGS; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; JOINT DISEASES; LENGTH OF STAY; MALE; MIDDLE AGED; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84964702665     PISSN: 10225536     EISSN: 23094990     Source Type: Journal    
DOI: 10.1177/230949901602400103     Document Type: Article

References (24)

1. Kalairajah Y, Simpson D, Cossey AJ, Verrall GM, Spriggins AJ. Blood loss after total knee replacement: effects of computer-assisted surgery. J Bone Joint Surg Br 2005;87:1480–2.
2. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br 2004;86:561–5.
3. Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology 2000;93:242–55.
4. Forbes JM, Anderson MD, Anderson GF, Bleecker GC, Rossi EC, Moss GS. Blood transfusion costs: a multicenter study. Transfusion 1991;31:318–23.
5. Longstaff C. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinolysis 1994;5:537–42.
6. Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology 2006;105:1034–46.
7. Huang F, Wu D, Ma G, Yin Z, Wang Q. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res 2014;186:318–27.
8. Dahuja A, Dahuja G, Jaswal V, Sandhu K. A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty 2014;29:733–5.
9. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011;93:1577–85.
10. Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S. An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28(8 Suppl):74–7.
11. Gillette BP, Maradit Kremers H, Duncan CM, Smith HM, Trousdale RT, Pagnano MW, et al. Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013;28(8 Suppl):137–9.
12. Irwin A, Khan SK, Jameson SS, Tate RC, Copeland C, Reed MR. Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacement: results of 3000 procedures. Bone Joint J 2013;95-B:1556–61.
13. Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014;29:1512–5.
14. Yang ZG, Chen WP, Wu LD. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012;94:1153–9.
15. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013;6:184.
16. Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev 2013;7:CD010562.
17. Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, et al. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int Orthop 2011;35:1639–45.
18. Seo JG, Moon YW, Park SH, Kim SM, Ko KR. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 2013;21:1869–74.
19. Pispati A GP, Patil N, Savedekar A, Jaiswal N, Kumar A. Is intraarticular administration of tranexamic acid better than its intravenous administration in reducing blood loss after total knee arthroplasty? J Orthop Allied Sci 2013;1:28–32.
20. Soni A, Saini R, Gulati A, Paul R, Bhatty S, Rajoli SR. Comparison between intravenous and intra-articular regimens of tranexamic acid in reducing blood loss during total knee arthroplasty. J Arthroplasty 2014;29:1525–7.
21. Cordoba R, Tapia B, Aramburu O, Maria-Asuncion M, Bielza R, Escalera J, et al. Tranexamic acid reduces blood transfusion, postoperative blood loss and length of hospital stay in total knee arthroplasty. J Blood Disorders Transf 2014;5:207.
22. Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 2013;95:1961–8.
23. Gilbody J, Dhotar HS, Perruccio AV, Davey JR. Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 2014;29:681–4.
24. Shen PF, Hou WL, Chen JB, Wang B, Qu YX. Effectiveness and safety of tranexamic acid for total knee arthroplasty: a prospective randomized controlled trial. Med Sci Monit 2015;21:576–81.